|
RPL23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.936800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.257800E-01 |
| Normal-vs-Stage2 |
9.868800E-01 |
| Normal-vs-Stage3 |
1.855750E-01 |
| Normal-vs-Stage4 |
6.489800E-01 |
| Stage1-vs-Stage2 |
4.704200E-01 |
| Stage1-vs-Stage3 |
4.287600E-01 |
| Stage1-vs-Stage4 |
7.983800E-01 |
| Stage2-vs-Stage3 |
2.335400E-01 |
| Stage2-vs-Stage4 |
6.963800E-01 |
| Stage3-vs-Stage4 |
4.117000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.884200E-01 |
| Normal-vs-AfricanAmerican |
8.153000E-01 |
| Normal-vs-Asian |
3.947400E-01 |
| Caucasian-vs-AfricanAmerican |
8.114600E-01 |
| Caucasian-vs-Asian |
6.786000E-01 |
| AfricanAmerican-vs-Asian |
6.343800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.728000E-01 |
| Normal-vs-Female |
4.780800E-01 |
| Male-vs-Female |
5.568200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.015800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.292000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.252200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.161400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.427200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.122400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.257200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.336000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.953400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.134000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.305600E-01 |
| Classical-VS-Follicular |
9.033200E-01 |
| Classical-VS-Other |
9.092000E-02 |
| Classical-VS-Normal |
3.913000E-01 |
| Tall-VS-Follicular |
7.704800E-01 |
| Tall-VS-Other |
1.043370E-01 |
| Tall-VS-Normal |
4.105400E-01 |
| Follicular-VS-Other |
1.444570E-01 |
| Follicular-VS-Normal |
5.516000E-01 |
| Other-VS-Normal |
5.223800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.675000E-01 |
| Normal-vs-N1 |
9.250400E-01 |
| N0-vs-N1 |
4.001200E-01 |
|
|
